Skip to content

Drug interactions

Mifepristone + Selexipag

Severity: Moderate

Mifepristone and Selexipag: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone may inhibit CYP2C8, which forms the active metabolite of selexipag, and so may alter selexipag exposure. This could increase prostacyclin-type adverse effects such as headache, flushing, diarrhea and hypotension.

What this interaction means in plain words

Mifepristone and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mifepristone belongs to Endocrine; Selexipag belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP2C8-mediated metabolism of selexipag.

What to do

Consider reducing selexipag to once-daily dosing as advised for moderate CYP2C8 inhibitors, and monitor tolerability and blood pressure.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mifepristone and Selexipag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mifepristone with Selexipag?

MediHelp rates the interaction as moderate. Mifepristone and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mifepristone may inhibit CYP2C8, which forms the active metabolite of selexipag, and so may alter selexipag exposure. This could increase prostacyclin-type adverse effects such as headache, flushing, diarrhea and hypotension.

How serious is the interaction between Mifepristone and Selexipag?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing selexipag to once-daily dosing as advised for moderate CYP2C8 inhibitors, and monitor tolerability and blood pressure.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in